US Compounding Pharmacies Market Forecast to 2027 - COVID-19 Impact and Country Analysis by Product (Oral Medications, Topical Medications, Suppositories, and Others) and Therapeutic Area (Pain Medications, Hormone Replacement Therapies, Dermatological Applications, and Others)
Market Introduction
In the US compounding pharmacies market, conventional compounding pharmacies operate without the supervision of the US FDA. The State Boards of Pharmacy is engaged in regulation of the conventional compounding, also known as ‘within border’ compounding pharmacies. The US Pharmacopeia (USP) has set the standards for pharmacy compounding practices in most states. US compounding pharmacies operate through five main channels: independent store, compounding departments in hospital, part of a big retail drug manufacturer chain, store with an online order-delivery system, and multiple-location shops. In the US, compounding pharmacies are majorly found in independent store format.
Get more information on this report : 
Market Overview and Dynamics
The US compounding pharmacies market is expected to reach US$ 5,069.56 million by 2027 from US$ 3,079.64 million in 2019. The market is anticipated to grow at a CAGR of 6.5% from 2020 to 2027. Factors driving the market include the drug shortage crisis in the US and benefits associated with compounded medications. However, product recalls and stringent regulatory requirements are likely to hinder the market growth during the forecast period.
Key Market Segments
In terms of product, the oral medications segment held the largest share of the market in 2019; however, the topical medications segment is anticipated to register the highest CAGR in the market during the forecast period. In terms of therapeutic area, the pain medications segment held the largest share in 2019 and the same segment is estimated to register the largest market share during the forecast period.
Major Sources
Alliance for Pharmacy Compounding, Compounders' Shortage Drug Source for Hospitals, International Academy of Compounding Pharmacists, National Health Service, National Association of Specialty Pharmacy, and World Health Organization are among the major primary and secondary sources for the US compounding pharmacies market included in the report.
Reasons to Buy Report
- To understand the US compounding pharmacies market landscape and identify market segments that are most likely to guarantee a strong return
- To stay ahead of the race by comprehending the ever-changing competitive landscape for the US compounding pharmacies market
- To efficiently plan M&A and partnership deals in the US compounding pharmacies market by identifying market segments with the most promising probable sales
- To help in taking knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segments that form the US compounding pharmacies market
- To obtain the market revenue forecast for market by various segments from 2019 to 2027 in the US
US Compounding Pharmacies Market Segmentation
By Product
- Oral Medications
- Topical Medications
- Suppositories
- Others
By Therapeutic Area
- Pain Medications
- Dermatological Applications
- Hormone Replacement Therapies
- Others
Company Profiles
- Fagron
- Triangle compounding pharmacy
- Institutional pharmacy solutions, LLC
- B. Braun melsungen ag
- Pharmedium services LLC
- Fresenius kabi ag
- Avella specialty pharmacy
- Pencol Compounding Pharmacy
- Vertisis custom pharmacy
- US Compounding Inc.
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 US Compounding Pharmacies Market – By Product
1.3.2 US Compounding Pharmacies Market – By Therapeutic Area
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. US Compounding Pharmacies Market Landscape
4.1 Market Overview
4.2 PEST Analysis
4.2.1 US: PEST Analysis
4.3 Expert Opinion
5. US Compounding Pharmacies Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Drug Shortage Crisis in US
5.1.2 Benefits Associated with Compounded Medications
5.2 Market Restraints
5.2.1 Product Recalls and Stringent Regulatory Requirements
5.3 Market Opportunities
5.3.1 Growing Demand for Compounding Pharmacy During COVID-19
5.4 Future Trends
5.4.1 Growing Outsourcing Facilities for Manufacturing and Sales of Products
5.5 Impact Analysis
6. Compounding Pharmacies– US Market Analysis
6.1 US Compounding Pharmacies Market Overview
6.2 Market Positioning of Key Players
7. US Compounding Pharmacies Market Analysis– Product
7.1 Overview
7.2 US Compounding Pharmacies Market, by Product 2019 & 2027 (%)
7.3 Oral Medications
7.3.1 Overview
7.3.2 US Oral Medications Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 Topical Medications
7.4.1 Overview
7.4.2 US Topical Medications Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Suppositories
7.5.1 Overview
7.5.2 US Suppositories Market Revenue and Forecasts to 2027 (US$ Mn)
7.6 Others
7.6.1 Overview
7.6.2 Others Market Revenue and Forecasts to 2027 (US$ Mn)
8. US Compounding Pharmacies Market Analysis – Therapeutic Area
8.1 Overview
8.2 US Compounding Pharmacies Market, By Therapeutic Area 2019 & 2027 (%)
8.3 Pain Medications
8.3.1 Overview
8.3.2 US Pain Medications Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Hormone Replacement Therapies
8.4.1 Overview
8.4.2 US Hormone Replacement Therapies Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Dermatological Applications
8.5.1 Overview
8.5.2 US Dermatological Applications Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Others
8.6.1 Overview
8.6.2 US Others Market Revenue and Forecasts to 2027 (US$ Mn)
9. Impact of COVID-19 Pandemic on US Compounding Pharmacies Market
9.1 US: Impact Assessment of COVID-19 Pandemic
10. Industry Landscape
10.1 Overview
10.2 Growth Strategies Done by the Companies in the Market, (%)
10.3 Organic Developments
10.3.1 Overview
10.4 Inorganic Developments
10.4.1 Overview
11. Company Profiles
11.1 Fagron, Inc.
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Triangle Compounding Pharmacy
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Institutional Pharmacy Solutions, LLC
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 B.Braun Melsungen AG
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 PharMEDium Healthcare Holdings, Inc.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Fresenius Kabi AG
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Avella specialty pharmacy
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Pencol Compounding Pharmacy
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Vertisis Custom Pharmacy
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
1.44 US Compounding Inc.
1.44.1 Key Facts
1.44.2 Business Description
1.44.3 Products and Services
1.44.4 Financial Overview
1.44.5 SWOT Analysis
1.44.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms
LIST OF TABLES
Table 1. A few drugs that are in short supply are listed below:
Table 2. Organic Developments Done By Companies
Table 3. Inorganic Developments Done By Companies
Table 4. Glossary of Terms, US Compound Pharmacies Market
LIST OF FIGURES
Figure 1. US Compounding Pharmacies Market Segmentation
Figure 2. US Compounding Pharmacies Market Overview
Figure 3. Topical Medication is Expected to Show Remarkable Growth During Forecast Period
Figure 4. US Compounding Pharmacies Market, Industry Landscape
Figure 5. US: PEST Analysis
Figure 6. Expert Opinion
Figure 7. US Compounding Pharmacies Market Impact Analysis of Drivers and Restraints
Figure 8. Overview of US Compounding Pharmacies Market
Figure 9. Market Positioning Of Key Players In US Compounding Pharmacies Market
Figure 10. US Compounding Pharmacies Market, By Product 2019 & 2027 (%)
Figure 11. US Oral Medications Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. US Topical Medications Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 13. US Suppositories Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 14. US Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 15. US Compounding Pharmacies Market, by Therapeutic Area 2019 & 2027 (%)
Figure 16. US Pain Medications Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 17. US Hormone Replacement Therapies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. US Dermatological Applications Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 19. US Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. Impact of COVID-19 Pandemic on Compounding Pharmacies Market in the US
Figure 21. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies - US Compounding Pharmacies Market
- Fagron
- Triangle compounding pharmacy
- Institutional pharmacy solutions, llc
- B. Braun melsungen ag
- Pharmedium services llc
- Fresenius kabi ag
- Avella specialty pharmacy
- Pencol Compounding Pharmacy
- Vertisis custom pharmacy
- US Compounding Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the US compounding pharmacy market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the US compounding pharmacy market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.